"mean ADC values: >1.5-3.0 x 10-3 mm2/s with exception of fat-containing tumours"
"mean ADC values: >1.2-2.0 x 10-3 mm2/s with caution in myxoid lesions and giant cell tumour of bone"
"mean ADC values: >1.1-1.2 x 10-3 mm2/s with caution in myxoid lesions and giant cell tumour of bone"
"mean ADC values:"
"mean ADC values: >1.5-3.0 x 10-3 mm2/s with exception of fat-containing tumours"
"mean ADC values: >1.2-2.0 x 10-3 mm2/s with caution in myxoid lesions and giant cell tumour of bone"
"mean ADC values: >1.1-1.2 x 10-3 mm2/s with caution in myxoid lesions and giant cell tumour of bone"
"mean ADC values:"
"imaging criteria: solid nodule or residual mass in tumour bed with pre-interventional imaging features"
"Osseous Tumour Reporting and Data System (OT-RADS) is a reporting and communication tool designed to reliably identify benign and malignant bone tumours and to communicate them in a standardised way 1-3."
"The reliability of the OT-RADS system was validated based on a "complete MR imaging study" with the following predefined requirements 1:"
"The assessment categories were created using the BI-RADS as an example and based on the WHO classification of bone tumours. The assignment of categories in the OT-RADS seems to be based more on the typical MRI appearance of representative lesions with lesion-specific predefined imaging criteria than on generalised MRI signal characteristics 2,3 with some exceptions, such as about appearance on diffusion imaging and post-contrast enhancement."
"The assessment categories were created using the BI-RADS as an example and based on the WHO classification of bone tumours. The assignment of categories in the OT-RADS seems to be based more on the typical MRI appearance of representative lesions with lesion-specific predefined imaging criteria than on generalised MRI signal characteristics 2,3 with some exceptions, such as about appearance on diffusion imaging and post-contrast enhancement."
"OT-RADS 0"
"OT-RADS 1"
"OT-RADS 2"
"OT-RADS 3"
"OT-RADS 4"
"imaging follow-up as per OT-RADS 3 category in the setting of negative or indeterminate histology"
"OT-RADS 5"
"OT-RADS 6"
"OT-RADS was first published by Chhabra et al. in 2021 1."
"Solitary bone tumour imaging reporting and data system (BTI-RADS)"
"Bone Reporting and Data System (Bone-RADS)"
"Reporting and Data Systems (RADS): list of all RADS"
"Reporting and Data Systems (RADS): list of all RADS"
"Langerhans cell histiocytosis: in children and young adults"
"Ewing sarcoma"
"Solitary bone tumour imaging reporting and data system (BTI-RADS)"
"Bone Reporting and Data System (Bone-RADS)"
"Reporting and Data Systems (RADS): list of all RADS"
Expected headings
"OT-RADS 0"
"OT-RADS 1"
"OT-RADS 2"
"OT-RADS 3"
"OT-RADS 4"
"OT-RADS 5"
"OT-RADS 6"